Financhill
Back

Cartesian Therapeutics Quote, Financials, Valuation and Earnings

Cartesian Therapeutics Price Quote

$12.91
-0.07 (-7.65%)
(Updated: September 7, 2024 at 6:52 AM ET)

Cartesian Therapeutics Key Stats

Sell
25
Cartesian Therapeutics (RNAC) is a Sell

Day range:
$12.80 - $14.28
52-week range:
$11.67 - $42.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.02
P/B ratio:
0%

Volume:
53.5K
Avg. volume:
85.2K
1-year change:
-62.38%
Market cap:
$277.5M
Revenue:
$26M
EPS:
$-53.46

How Much Does Cartesian Therapeutics Make?

Is Cartesian Therapeutics Growing As A Company?

Cartesian Therapeutics Stock Price Performance

What Is Cartesian Therapeutics 52-Week High & Low?

Cartesian Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cartesian Therapeutics?

Is Cartesian Therapeutics Cash Flow Positive?

  • What Is RNAC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$62.9M
  • What Is Cartesian Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $32.4M
  • What Is Cartesian Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $4.3M

Cartesian Therapeutics Return On Invested Capital

Data Unavailable

Cartesian Therapeutics Earnings Date & Stock Price

Cartesian Therapeutics Competitors

Cartesian Therapeutics Dividend Yield

Cartesian Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 770.53%
Revenue: 537.17% 507.4%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 41.60
Upside from Last Price: 220.49%

Major Shareholders

  • How many RNAC shares are owned by institutional investors?
    17.5M RNAC shares are owned by institutional investors
  • How many RNAC shares are owned by insiders?
    15.8M RNAC shares are owned by insiders